“Is the Neoadjuvant Docetaxel, Cisplatin and 5-Fluorouracil Regimen Superior to Classic Cisplatin and 5-Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma?”. Journal of Cancer Research Updates 2, no. 4 (November 28, 2013):  297–305. Accessed October 25, 2025. https://neoplasiaresearch.com/index.php/jcru/article/view/427.